Paid Clinical Trials for Glioblastoma

Showing 41 – 60 of 71 results

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

by CTG

in Glioblastoma, Brain Tumor

Other

Ohio

Deadline:

12/31/2029

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

by CTG

in Glioblastoma, Gliosarcoma

Other

New Jersey

Deadline:

04/01/2028

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

by CTG

in Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain, Glioblastoma Multiforme, Adult

Other

California

Deadline:

01/01/2029

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

by CTG

in Glioblastoma

Other

Alabama

Deadline:

06/01/2030

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma

by CTG

in Glioblastoma, Glioblastoma Multiforme

Other

Florida

Deadline:

12/01/2042

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

by CTG

in Glioblastoma, High Grade Glioma

Other

Arizona

Deadline:

12/01/2027

Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue

by CTG

in Glioblastoma

Other

Ohio

Deadline:

06/01/2026

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

by CTG

in Glioblastoma

Other

New York

Deadline:

05/12/2029

GammaTile and Stupp in Newly Diagnosed GBM

by CTG

in Glioblastoma

Other

Arizona

Deadline:

12/01/2027

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

by CTG

in Glioblastoma, IDH-wildtype, Glioblastoma, Brain Neoplasms, Glioblastoma Multiforme of Brain, Astrocytoma, Malignant

Other

California

Deadline:

01/01/2028

Glioblastoma Remote Monitoring and Care – Research Protocol

by CTG

in Glioblastoma, Venous Thromboembolism, Seizures

Other

Ohio

Deadline:

12/01/2027

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

by CTG

in Glioblastoma

Other

Wisconsin

Deadline:

03/01/2027

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

by CTG

in Glioblastoma, Advanced Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Glioma, Recurrent Cholangiocarcinoma

Other

California

Deadline:

07/28/2026

Phase I Trial of pH Resections of GBM at VA

by CTG

in Glioblastoma

Other

California

Deadline:

02/01/2031

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

by CTG

in Brain Cancer, Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant, GBM

Other

New York

Deadline:

04/01/2028

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

by CTG

in Glioblastoma, Glioma, Malignant Glioma, Low Grade Glioma, High Grage Glioma

Other

Maryland

Deadline:

02/27/2026

CARv3-TEAM-E T Cells in Glioblastoma

by CTG

in Glioblastoma, Recurrent Glioblastoma, Malignant Glioma, Recurrent Glioma

Other

Massachusetts

Deadline:

06/01/2026

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

by CTG

in Medulloblastoma, Glioblastoma, Ependymoma, Diffuse Intrinsic Pontine Glioma

Other

Georgia

Deadline:

10/02/2027

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

by CTG

in Glioblastoma, Recurrent Glioblastoma, GBM

Other

Florida

Deadline:

06/30/2028

Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma

by CTG

in Glioblastoma

Other

North Carolina

Deadline:

11/01/2026

Load more All clinical trials loaded.

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

GammaTile and Stupp in Newly Diagnosed GBM

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Glioblastoma Remote Monitoring and Care – Research Protocol

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Phase I Trial of pH Resections of GBM at VA

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

CARv3-TEAM-E T Cells in Glioblastoma

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Glioblastoma

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps